1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Craik, D.J. Norman, D.G. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 1 90.00 90.00 90.00 1.000 1.000 1.000 C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C11 H12 N2 O2 204.225 y TRYPTOPHAN L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking US Biochemistry BICHAW 0033 0006-2960 34 4147 4158 10.1021/bi00013a002 7703226 Elucidation of the primary and three-dimensional structure of the uterotonic polypeptide kalata B1. 1995 NO Medd.Nor.Farm.Selsk. MNFSAW 2057 0029-1927 32 173 An Oxytocic Principle Found in Oldenlandia Affinis Dc 1970 10.2210/pdb1kal/pdb pdb_00001kal 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 2917.344 KALATA B1 1 man polymer no no SWPVCTRNGLPVCGETCVGGTCNTPGCTC SWPVCTRNGLPVCGETCVGGTCNTPGCTC A polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n Oldenlandia sample 60225 Oldenlandia affinis database_2 pdbx_database_status pdbx_struct_assembly pdbx_struct_oper_list repository Initial release Version format compliance Version format compliance Database references Derived calculations Other 1 0 1995-03-31 1 1 2008-03-24 1 2 2011-07-13 1 3 2022-02-23 _database_2.pdbx_DOI _database_2.pdbx_database_accession _pdbx_database_status.process_site Y BNL 1995-01-13 REL REL 10 BRUNGER refinement X-PLOR SER 1 n 1 SER 1 A TRP 2 n 2 TRP 2 A PRO 3 n 3 PRO 3 A VAL 4 n 4 VAL 4 A CYS 5 n 5 CYS 5 A THR 6 n 6 THR 6 A ARG 7 n 7 ARG 7 A ASN 8 n 8 ASN 8 A GLY 9 n 9 GLY 9 A LEU 10 n 10 LEU 10 A PRO 11 n 11 PRO 11 A VAL 12 n 12 VAL 12 A CYS 13 n 13 CYS 13 A GLY 14 n 14 GLY 14 A GLU 15 n 15 GLU 15 A THR 16 n 16 THR 16 A CYS 17 n 17 CYS 17 A VAL 18 n 18 VAL 18 A GLY 19 n 19 GLY 19 A GLY 20 n 20 GLY 20 A THR 21 n 21 THR 21 A CYS 22 n 22 CYS 22 A ASN 23 n 23 ASN 23 A THR 24 n 24 THR 24 A PRO 25 n 25 PRO 25 A GLY 26 n 26 GLY 26 A CYS 27 n 27 CYS 27 A THR 28 n 28 THR 28 A CYS 29 n 29 CYS 29 A author_defined_assembly 1 monomeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 A N ARG 7 A N ARG 7 A O LEU 10 A O LEU 10 1 A A N C SER CYS 1 29 1.30 2 A A N C SER CYS 1 29 1.30 3 A A N C SER CYS 1 29 1.30 4 A A N C SER CYS 1 29 1.31 5 A A N C SER CYS 1 29 1.30 6 A A N C SER CYS 1 29 1.30 7 A A N C SER CYS 1 29 1.30 8 A A N C SER CYS 1 29 1.30 9 A A N C SER CYS 1 29 1.30 10 A A N C SER CYS 1 29 1.30 1 A ARG 7 0.309 SIDE CHAIN 2 A ARG 7 0.309 SIDE CHAIN 3 A ARG 7 0.182 SIDE CHAIN 4 A ARG 7 0.315 SIDE CHAIN 5 A ARG 7 0.289 SIDE CHAIN 6 A ARG 7 0.311 SIDE CHAIN 8 A ARG 7 0.301 SIDE CHAIN 9 A ARG 7 0.279 SIDE CHAIN 10 A ARG 7 0.283 SIDE CHAIN 1 -22.69 2.70 111.00 88.31 A A A N CA C SER SER SER 1 1 1 N 1 -6.78 1.00 110.10 103.32 A A A CG CD1 NE1 TRP TRP TRP 2 2 2 N 1 7.59 0.90 109.00 116.59 A A A CD1 NE1 CE2 TRP TRP TRP 2 2 2 N 1 8.26 1.10 130.40 138.66 A A A NE1 CE2 CZ2 TRP TRP TRP 2 2 2 N 2 -23.98 2.70 111.00 87.02 A A A N CA C SER SER SER 1 1 1 N 2 -6.82 1.00 110.10 103.28 A A A CG CD1 NE1 TRP TRP TRP 2 2 2 N 2 7.55 0.90 109.00 116.55 A A A CD1 NE1 CE2 TRP TRP TRP 2 2 2 N 2 7.85 1.10 130.40 138.25 A A A NE1 CE2 CZ2 TRP TRP TRP 2 2 2 N 3 -23.20 2.70 111.00 87.80 A A A N CA C SER SER SER 1 1 1 N 3 -6.86 1.00 110.10 103.24 A A A CG CD1 NE1 TRP TRP TRP 2 2 2 N 3 7.60 0.90 109.00 116.60 A A A CD1 NE1 CE2 TRP TRP TRP 2 2 2 N 3 7.94 1.10 130.40 138.34 A A A NE1 CE2 CZ2 TRP TRP TRP 2 2 2 N 4 -21.39 2.70 111.00 89.61 A A A N CA C SER SER SER 1 1 1 N 4 -6.77 1.00 110.10 103.33 A A A CG CD1 NE1 TRP TRP TRP 2 2 2 N 4 7.41 0.90 109.00 116.41 A A A CD1 NE1 CE2 TRP TRP TRP 2 2 2 N 4 7.53 1.10 130.40 137.93 A A A NE1 CE2 CZ2 TRP TRP TRP 2 2 2 N 5 -23.76 2.70 111.00 87.24 A A A N CA C SER SER SER 1 1 1 N 5 -7.22 1.00 110.10 102.88 A A A CG CD1 NE1 TRP TRP TRP 2 2 2 N 5 7.53 0.90 109.00 116.53 A A A CD1 NE1 CE2 TRP TRP TRP 2 2 2 N 5 7.43 1.10 130.40 137.83 A A A NE1 CE2 CZ2 TRP TRP TRP 2 2 2 N 6 -23.38 2.70 111.00 87.62 A A A N CA C SER SER SER 1 1 1 N 6 -7.17 1.00 110.10 102.93 A A A CG CD1 NE1 TRP TRP TRP 2 2 2 N 6 7.71 0.90 109.00 116.71 A A A CD1 NE1 CE2 TRP TRP TRP 2 2 2 N 6 7.49 1.10 130.40 137.89 A A A NE1 CE2 CZ2 TRP TRP TRP 2 2 2 N 7 -23.57 2.70 111.00 87.43 A A A N CA C SER SER SER 1 1 1 N 7 -6.82 1.00 110.10 103.28 A A A CG CD1 NE1 TRP TRP TRP 2 2 2 N 7 7.55 0.90 109.00 116.55 A A A CD1 NE1 CE2 TRP TRP TRP 2 2 2 N 7 8.52 1.10 130.40 138.92 A A A NE1 CE2 CZ2 TRP TRP TRP 2 2 2 N 7 7.24 1.10 114.20 121.44 A A A CA CB SG CYS CYS CYS 5 5 5 N 8 -23.46 2.70 111.00 87.54 A A A N CA C SER SER SER 1 1 1 N 8 -7.21 1.00 110.10 102.89 A A A CG CD1 NE1 TRP TRP TRP 2 2 2 N 8 7.74 0.90 109.00 116.74 A A A CD1 NE1 CE2 TRP TRP TRP 2 2 2 N 8 7.76 1.10 130.40 138.16 A A A NE1 CE2 CZ2 TRP TRP TRP 2 2 2 N 8 10.56 1.10 114.20 124.76 A A A CA CB SG CYS CYS CYS 5 5 5 N 9 -22.32 2.70 111.00 88.68 A A A N CA C SER SER SER 1 1 1 N 9 -6.87 1.00 110.10 103.23 A A A CG CD1 NE1 TRP TRP TRP 2 2 2 N 9 7.60 0.90 109.00 116.60 A A A CD1 NE1 CE2 TRP TRP TRP 2 2 2 N 9 7.78 1.10 130.40 138.18 A A A NE1 CE2 CZ2 TRP TRP TRP 2 2 2 N 10 -22.31 2.70 111.00 88.69 A A A N CA C SER SER SER 1 1 1 N 10 -6.86 1.00 110.10 103.24 A A A CG CD1 NE1 TRP TRP TRP 2 2 2 N 10 7.51 0.90 109.00 116.51 A A A CD1 NE1 CE2 TRP TRP TRP 2 2 2 N 10 8.01 1.10 130.40 138.41 A A A NE1 CE2 CZ2 TRP TRP TRP 2 2 2 N 10 7.48 1.10 114.20 121.68 A A A CA CB SG CYS CYS CYS 17 17 17 N 1 A TRP 2 -0.46 -70.19 1 A PRO 11 -48.72 100.98 1 A CYS 17 -140.78 42.11 1 A PRO 25 -38.36 111.18 2 A TRP 2 1.45 -71.86 2 A PRO 11 -50.73 81.56 2 A VAL 12 -150.44 42.05 2 A CYS 17 -140.88 40.46 2 A CYS 22 -121.19 -50.38 3 A TRP 2 2.11 -71.77 3 A PRO 11 -50.00 83.42 3 A VAL 12 -147.11 48.40 4 A TRP 2 -5.74 -65.48 4 A PRO 11 -51.24 85.71 4 A VAL 12 -151.03 31.32 4 A CYS 17 -147.53 43.18 4 A THR 21 -120.13 -73.44 4 A CYS 22 59.44 -73.92 5 A TRP 2 -0.98 -67.87 5 A PRO 11 -52.61 83.51 5 A VAL 12 -163.47 41.36 5 A CYS 17 -142.26 40.76 5 A THR 21 -106.50 -60.78 5 A CYS 22 -4.60 -73.95 5 A ASN 23 21.04 57.61 5 A PRO 25 -57.10 102.65 6 A TRP 2 -2.46 -67.31 6 A PRO 11 -51.49 83.80 6 A VAL 12 -146.53 39.37 6 A CYS 17 -142.59 39.42 6 A THR 21 -124.92 -141.28 6 A CYS 22 115.70 -70.11 6 A ASN 23 30.62 52.46 7 A TRP 2 2.86 -72.64 7 A PRO 11 -52.65 93.50 7 A VAL 12 -141.42 36.84 7 A CYS 17 -143.39 41.54 7 A THR 21 -130.19 -141.29 7 A CYS 22 122.75 -64.10 7 A ASN 23 37.59 57.50 7 A PRO 25 -58.96 91.57 8 A TRP 2 0.59 -69.05 8 A CYS 17 -141.98 40.10 8 A THR 21 -105.58 -84.63 8 A CYS 22 -6.34 99.00 9 A TRP 2 -4.03 -65.89 9 A ASN 8 36.39 46.86 9 A PRO 11 -60.18 91.64 9 A CYS 17 -146.05 42.75 9 A THR 21 -127.34 -99.74 9 A CYS 22 90.83 -59.75 10 A TRP 2 0.28 -69.61 10 A VAL 12 146.20 50.50 10 A THR 21 169.34 159.55 model building X-PLOR refinement X-PLOR phasing X-PLOR ELUCIDATION OF THE PRIMARY AND THREE-DIMENSIONAL STRUCTURE OF THE UTEROTONIC POLYPEPTIDE KALATA B1 1 Y N disulf 2.021 A CYS 5 A SG CYS 5 1_555 A CYS 22 A SG CYS 22 1_555 disulf 2.017 A CYS 13 A SG CYS 13 1_555 A CYS 27 A SG CYS 27 1_555 disulf 2.020 A CYS 17 A SG CYS 17 1_555 A CYS 29 A SG CYS 29 1_555 PLANT PROTEIN PLANT PROTEIN KAB1_OLDAF UNP 1 1 P56254 TCVGGTCNTPGCTCSWPVCTRNGLPVCGE 15 29 1KAL 1 15 P56254 A 1 1 15 2 anti-parallel A THR 6 A THR 6 A ARG 7 A ARG 7 A LEU 10 A LEU 10 A PRO 11 A PRO 11 1 P 1